COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE ANALOGS AS INHIBITORS OF KRAS
In one aspect, the disclosure relates to compounds useful as inhibitors of mutant KRAS proteins, methods of making the same, pharmaceutical compositions comprising the same, and methods of treating cancers associated with mutated forms of KRAS using the same. This abstract is intended as a scanning...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ABEBE, Alemayehu DILSHA, Kasuni GILBERTSON, Scott PAGBA, Cynthia |
| description | In one aspect, the disclosure relates to compounds useful as inhibitors of mutant KRAS proteins, methods of making the same, pharmaceutical compositions comprising the same, and methods of treating cancers associated with mutated forms of KRAS using the same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Selon un aspect de l'invention, l'invention concerne des composés utiles en tant qu'inhibiteurs de protéines KRAS mutantes, leurs procédés de fabrication, des compositions pharmaceutiques les comprenant, et des méthodes de traitement de cancers associés à des formes mutées de KRAS les utilisant. Le présent abrégé est destiné à servir d'outil d'exploration à des fins de recherche dans la technique particulière et n'est pas destiné à limiter la présente invention |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021119343A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021119343A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021119343A13</originalsourceid><addsrcrecordid>eNqNjLEKwjAUALs4iPoPARcFA6ZVxDFtUvuwzQtJilSRUiROosX6_5jBD3A6Do4bR-8MK40WHKCyhCtBKukKFJbkaIitU-vA1U4KsqMLDVoafgZFGW3KpW6CYIkXttpSfg0KFQhQMnx4iYfwswRUASk4NJZgTo6G22k0unePwc9-nETzXLqsoL5_tX7ou5t_-k97wngdM8b2ySbhLPmv-gJS9jl1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE ANALOGS AS INHIBITORS OF KRAS</title><source>esp@cenet</source><creator>ABEBE, Alemayehu ; DILSHA, Kasuni ; GILBERTSON, Scott ; PAGBA, Cynthia</creator><creatorcontrib>ABEBE, Alemayehu ; DILSHA, Kasuni ; GILBERTSON, Scott ; PAGBA, Cynthia</creatorcontrib><description>In one aspect, the disclosure relates to compounds useful as inhibitors of mutant KRAS proteins, methods of making the same, pharmaceutical compositions comprising the same, and methods of treating cancers associated with mutated forms of KRAS using the same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Selon un aspect de l'invention, l'invention concerne des composés utiles en tant qu'inhibiteurs de protéines KRAS mutantes, leurs procédés de fabrication, des compositions pharmaceutiques les comprenant, et des méthodes de traitement de cancers associés à des formes mutées de KRAS les utilisant. Le présent abrégé est destiné à servir d'outil d'exploration à des fins de recherche dans la technique particulière et n'est pas destiné à limiter la présente invention</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210617&DB=EPODOC&CC=WO&NR=2021119343A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210617&DB=EPODOC&CC=WO&NR=2021119343A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ABEBE, Alemayehu</creatorcontrib><creatorcontrib>DILSHA, Kasuni</creatorcontrib><creatorcontrib>GILBERTSON, Scott</creatorcontrib><creatorcontrib>PAGBA, Cynthia</creatorcontrib><title>COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE ANALOGS AS INHIBITORS OF KRAS</title><description>In one aspect, the disclosure relates to compounds useful as inhibitors of mutant KRAS proteins, methods of making the same, pharmaceutical compositions comprising the same, and methods of treating cancers associated with mutated forms of KRAS using the same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Selon un aspect de l'invention, l'invention concerne des composés utiles en tant qu'inhibiteurs de protéines KRAS mutantes, leurs procédés de fabrication, des compositions pharmaceutiques les comprenant, et des méthodes de traitement de cancers associés à des formes mutées de KRAS les utilisant. Le présent abrégé est destiné à servir d'outil d'exploration à des fins de recherche dans la technique particulière et n'est pas destiné à limiter la présente invention</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEKwjAUALs4iPoPARcFA6ZVxDFtUvuwzQtJilSRUiROosX6_5jBD3A6Do4bR-8MK40WHKCyhCtBKukKFJbkaIitU-vA1U4KsqMLDVoafgZFGW3KpW6CYIkXttpSfg0KFQhQMnx4iYfwswRUASk4NJZgTo6G22k0unePwc9-nETzXLqsoL5_tX7ou5t_-k97wngdM8b2ySbhLPmv-gJS9jl1</recordid><startdate>20210617</startdate><enddate>20210617</enddate><creator>ABEBE, Alemayehu</creator><creator>DILSHA, Kasuni</creator><creator>GILBERTSON, Scott</creator><creator>PAGBA, Cynthia</creator><scope>EVB</scope></search><sort><creationdate>20210617</creationdate><title>COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE ANALOGS AS INHIBITORS OF KRAS</title><author>ABEBE, Alemayehu ; DILSHA, Kasuni ; GILBERTSON, Scott ; PAGBA, Cynthia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021119343A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ABEBE, Alemayehu</creatorcontrib><creatorcontrib>DILSHA, Kasuni</creatorcontrib><creatorcontrib>GILBERTSON, Scott</creatorcontrib><creatorcontrib>PAGBA, Cynthia</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ABEBE, Alemayehu</au><au>DILSHA, Kasuni</au><au>GILBERTSON, Scott</au><au>PAGBA, Cynthia</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE ANALOGS AS INHIBITORS OF KRAS</title><date>2021-06-17</date><risdate>2021</risdate><abstract>In one aspect, the disclosure relates to compounds useful as inhibitors of mutant KRAS proteins, methods of making the same, pharmaceutical compositions comprising the same, and methods of treating cancers associated with mutated forms of KRAS using the same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Selon un aspect de l'invention, l'invention concerne des composés utiles en tant qu'inhibiteurs de protéines KRAS mutantes, leurs procédés de fabrication, des compositions pharmaceutiques les comprenant, et des méthodes de traitement de cancers associés à des formes mutées de KRAS les utilisant. Le présent abrégé est destiné à servir d'outil d'exploration à des fins de recherche dans la technique particulière et n'est pas destiné à limiter la présente invention</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2021119343A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE ANALOGS AS INHIBITORS OF KRAS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A17%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ABEBE,%20Alemayehu&rft.date=2021-06-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021119343A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |